Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior ...

Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...

Weight loss drugs Ozempic and Wegovy would no longer be covered by California's health insurance for low-income people under ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries ...